Evidence-Based Guidelines 101
NCC partners with the American College of Medical Genetics and Genomics for our Evidence-Based Guidelines 101. In 2021, ACMG published its first Evidence-Based Guideline and continues to expand these guidelines. To make these guidelines more accessible to the non-genetics provider audience, NCC hosts the Evidence-Based Guidelines 101 series.
Exome and genome sequencing for pediatric patients with congenital anomalities or intellectual disability
The first in our Evidence-Based Guidelines 101 series focuses on the first published Evidence-Based Guideline from ACMG- Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability of the American College of Medical Genetics and Genomics (ACMG).
Associated Links
This activity has been approved for 1.0 AMA PRA Category 1 Credit™. To access the course, please click the link below.
Please note that to access the module to obtain credit, you must have or register for a FREE user account within the ACMG Genetics Academy.
Interested in reading the published manuscript, click here!
Last Updated on July 6, 2023